Acacia Pharma has a portfolio of approved and near-market products targeting large and growing markets with significant unmet medical needs.
Postoperative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
View PONV video
For use during invasive medical procedures, such as colonoscopy and bronchoscopy.
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®
Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV
Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation
View all news